DailyIQ
DailyIQ
Last updated1 minute ago

CLX·The Clorox Company

$97.11
-2.59 (-2.60%)
High
$99.29
Open
$96.74
Market Cap
12.01B
52W High
$128.90
Low
$96.19
P. Close
$97.11
P/E
17.74
52W Low
$79.12
Fwd P/E
16.08
DailyIQ Est.
$88.63
Inst. Own.
69.5%
Short Interest
8.33%
Days to Cover
4.1
Div. Yield
5.02%
Next Ex-Div
~Jan 27
Div. Growth
42+ yrs
NewEarnings release, scored · filed Nov 2, 2026tone +17.1 vs prior release · 143 lines scoredSee the breakdown
Technical Score (1D)
14
BEARISH
News Sentiment
51
MIXED
On Nov 5, the ProShares S&P 500 Dividend Aristocrats ETF (NOBL) added $3.3 million of Clorox Company (CLX) shares that it had purchased on Nov. 3, reflecting confidence in the company’s dividend stability and aligning with the fund’s focus on dividend aristocrats. That same day, NOBL’s net buying activity totaled $74.3 million, adding 67 positions and reducing only one. On Nov 4, Deutsche Bank raised its price target for CLX to $99 from $95 while maintaining a hold rating, indicating modest upside potential according to the bank’s assessment. Both reports highlight continued institutional interest in CLX, with the ETF’s purchase underscoring dividend appeal and the bank’s target adjustment signaling confidence in earnings and product strength.
LOW TARGET
$74 -23.8%
6 analysts
MEAN TARGET
$99 +1.6%
20 analysts
HIGH TARGET
$154 +58.6%
2 analysts
PRICE RANGE
$74.00 - $154.00
SB / B / H / S / SS
1/1/17/8/1
DAILYIQ EST.
$88.63 (-8.7%)
Sector
Consumer Defensive
Industry
Household & Personal Products
Exchange
NYQ
Country
United States
Symbol
CLX
Description
The Clorox Company is a global consumer staples manufacturer, primarily focused on household and healthcare essentials. Its diverse product portfolio spans four key segments: Health and Wellness, Household, Lifestyle, and International. Clorox's value proposition centers on providing trusted brands like Clorox, Glad, and Brita, offering consumers solutions for cleaning, home care, and personal wellness needs. The company distributes its products through a broad network of retailers, including mass merchants, grocery stores, and online channels, ensuring widespread accessibility. With a history dating back to 1913, Clorox has established a strong competitive position by consistently delivering essential products that meet everyday consumer demands.
Bought (1Y)
4,000 shares
$400K
Sold (1Y)
28,097 shares
$2.3M
Breber Pierre R-
Buy4,000 shares2026-11-04
Barton NinaEVP-Chief Growth & Strategy Of
Tax Withholding1,106 shares2026-10-05
Hilt Angela CEVP - Chief Legal Officer
Tax Withholding2,351 shares2026-10-05
Hilt Angela CEVP - Chief Legal Officer
Tax Withholding2,296 shares2026-10-05
Hilt Angela CEVP - Chief Legal Officer
Award/Grant6,637 shares2026-10-05
60/ 100
Neutral / mixed
Overall: Neutral
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Gross Margin
45.2%
Net Margin
11.4%
Revenue CAGR
1.8%
Current Ratio
0.84x
Debt / Equity
7.74x
Return on Equity
252.3%

EPS

EstBeatMiss
$0.65$0.93$1.22$1.51$1.79Q3'25Q2'26Q3'26Q4'26Q1'27Q2'27
QtrEstActual+/−
Q2'27$1.35 - -
Q1'27$1.08$1.55+44.1%
Q4'26$1.65$1.66+0.9%
Q3'26$1.55$1.64+6.1%
Q2'26$1.57$1.39-11.5%
Q3'25$0.78$0.85+9.2%

Revenue

EstBeatMiss
$1.4B$1.5B$1.7B$1.9B$2.0BQ3'25Q2'26Q3'26Q4'26Q1'27Q2'27
QtrEstActual+/−
Q2'27$1.9B - -
Q1'27$1.9B$1.9B+0.5%
Q4'26$1.9B$1.9B+1.6%
Q3'26$1.7B$1.7B+0.1%
Q2'26$1.7B$1.7B+0.0%
Q3'25 - $1.4B -

Market Data

CLX Stock Snapshot

BEARISH14/100
$97.11−$2.59 (2.6%)
Market cap
12.01B
P/E ratio
17.7
Day range
$96.19 – $99.29
News sentiment
51/100 · Neutral
Analyst target
$98.65 (+1.6%)
Consensus
Hold · 28 analysts
52-week range+22.7% off low · -24.7% from high
$79.12$128.90
Price $97.11 DailyIQ Est. $88.63

Price action on CLX is defensive - rallies are being sold rather than extended. In Consumer Defensive, names this size usually take direction from sector flows before company-level news.

Reverse DCF

What growth is priced into CLX?

CHEAP

At today's price, The Clorox Company needs to grow free cash flow about -4.4% a year for 3 years, slowing to a long-run rate by year 10, to justify its valuation at a 6.20% cost of capital. Over the last five years its revenue has trended at -0.7% a year, so the market is asking for 3.8 percentage points below its own delivered rate. On that basis CLX looks priced below what its own growth record supports.

Implied FCF growth
-4.4%
Growth trend
-0.7%
Growth gap
-3.8 pts
Verdict
CHEAP
Discount rate (WACC)
6.20%
Beta
0.48

Behaviour On Record

What CLX's own history says about today's numbers

Realized volatility (21d)
33.5% 91st pct
Below its peak
-57.7%
vs 200-day average
+1.4%
Up days (1y)
47%

The Clorox Company is currently running 33.5% annualised volatility over the last 21 sessions. Measured against CLX's own 13 years of daily returns rather than a market-wide average, that is the 91st percentile — an extreme by its own standards, against a typical reading of 19.5%.

CLX is trading -57.7% below its running peak. Across 13 full years on file, its median worst-drawdown-in-a-year was -20.4%, and the deepest was -40.1% in 2025. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began, and where past declines also continued.

Price sits +1.4% from its 200-day moving average. Against every other day in its history, that gap ranks at the 51st percentile — close to the gap it normally carries. Over the past year CLX closed higher on 47% of sessions, and it is currently 4 sessions into a rising streak.

On November specifically: over 13 years of records, CLX finished the month higher 8 of 13 times, with a median return of +1.1% and an average of +1.5%. Its strongest month historically has been June at +2.0% on average, its weakest September at -3.4%.

Overnight risk is measurable too: CLX has opened more than 2% away from the prior close in 53 of 3,268 sessions (1.6% of the time), with the largest gaps running +5.9% and -5.0%.

Across the last 4 dated reports on file, CLX moved an average of 4.4% in the session after earnings, closing higher 3 of those 4 times, with a median move of +4.7% and a largest of +5.8%.

All figures computed from 3,269 daily closes between 2013-11-06 and 2026-11-05, split-adjusted, recomputed daily. Percentiles are against CLX's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of CLX's sector?

The Clorox Company sits in the Consumer Staples sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (weakening).

Sector rank
#2 of 12
Sector state
Weakening
Sector rotation score
73

Options Market

What is the options market pricing for CLX?

CallsPuts

For The Clorox Company's nearest expiry (2026-11-20, 14 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.56), with at-the-money implied volatility around 6.3%. The options market is pricing roughly a ±1.2% move by that expiry — a range of about $96.24–$98.62.

Put/call ratio (2026-11-20)
0.56
ATM implied volatility
6.3%
Total open interest
22,670
Expected move by 2026-11-20
±1.2% ($96.24–$98.62)

Analyst Consensus Estimates

What do analysts expect CLX to earn?

Analysts expect The Clorox Company to earn $5.70 per share in the fiscal year ending Jun 2027 and $6.40 in the fiscal year ending Jun 2029, from 3 estimates. These are analyst forecasts, not company guidance, and later years rest on fewer analysts.

Quarter endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Sep 2026$1.07$0.81 to $1.2015$1.88B12
Dec 2026$1.34$1.22 to $1.4715$1.89B12
Mar 2027$1.64$1.49 to $1.916~$2.21B-
Sep 2027$1.03$0.78 to $1.195--
Fiscal year endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Jun 2027$5.70$5.30 to $5.8519$7.63B16
Jun 2028$6.13$5.64 to $6.5618$7.81B16
Jun 2029$6.40$5.98 to $6.893~$8.20B-

Revenue marked ~ is our calculation from the EPS estimate, not analyst consensus.

Analyst Rating Changes

Are analysts turning bullish or bearish on CLX?

Morgan Stanley most recently reiterated its rating on The Clorox Company to Equal-Weight on Nov 4, 2026 with a price target of $94 (from $87). Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.

Latest action
Morgan Stanley: Equal-Weight
90-day upgrades
1
90-day downgrades
0
Net rating momentum
+1
DateFirmActionRatingPrice target
Nov 4, 2026Morgan StanleyMaintainedEqual-Weight$87 → $94
Nov 3, 2026JP MorganMaintainedUnderweight$83 → $86
Nov 3, 2026UBSMaintainedNeutral$91 → $96
Nov 3, 2026Wells FargoMaintainedEqual-Weight$85 → $90
Nov 2, 2026Evercore ISI GroupUpgradeUnderperform → In-Line$99
Oct 19, 2026JP MorganMaintainedUnderweight$95 → $83
Oct 16, 2026BarclaysMaintainedUnderweight$84 → $80
Oct 15, 2026Morgan StanleyMaintainedEqual-Weight$97 → $87
Oct 14, 2026CitigroupMaintainedNeutral$97 → $90
Oct 13, 2026TD CowenMaintainedHold$85 → $80
Oct 5, 2026Wells FargoMaintainedEqual-Weight$90 → $85
Sep 11, 2026CitigroupMaintainedNeutral$100 → $97

Earnings Release, Scored

What did The Clorox Company's latest earnings release say?

Filed Nov 2, 2026 · SEC Form 8-K, Exhibit 99

Tone63.5/ 100+17.1 vs prior release
Hedging words1.25per 100 words+0.90 vs prior release
Tone, last 3 releasesScale 41–69

Most important lines

  1. 1

    Net sales increased 33% to $1.91 billion.

    New this quarter
  2. 2

    Net sales increased 11%.

    New this quarter
  3. 3

    Adjusted EPS growth rate reflects the impact of lapping the ERP transition-related inventory drawdown in the year-ago quarter, which was about 90 cents.

    New this quarter

Peers & ETF holders

CLX peers & ETF holders

News & sentiment

What is the news saying about CLX?

CLX rose 16.1% over the month to Nov 6. News tone held between 30 and 100 from Oct 6 to Oct 23, then dropped to 31 on Oct 26.

Daily close and news tone, Oct 6 to Nov 6
$90$100Oct 6: tone 53Oct 7: tone 92Oct 8: tone 49Oct 9Oct 12: tone 32Oct 13: tone 37Oct 14: tone 30Oct 15: tone 35Oct 16: tone 51Oct 19: tone 31Oct 20: tone 57Oct 21: tone 57Oct 22Oct 23: tone 100Oct 26: tone 31Oct 27: tone 21Oct 28: tone 52Oct 29: tone 46Oct 30: tone 38Nov 2: tone 67Nov 3: tone 52Nov 4: tone 45Nov 5: tone 38Nov 6Oct 6News toneNov 6123
  1. Oct 22 +4.5%
  2. Nov 2 +5.0%same day: ADRNY or CLX: Which Is the Better Value Stock Right Now?
  3. Nov 4 +5.7%same day: ETFs Are Net Sellers of Clorox (CLX) on Nov. 2

Technical analysis

How strong is CLX's momentum right now?

On the daily chart CLX ranks at the 14th percentile for momentum against 1,060 stocks and ETFs, a bearish reading.

Momentum rank by timeframe0 = weakest, 100 = strongest
See what drives the rankThe inputs behind each timeframe's momentum rank, plus RSI, stochastics, Bollinger Bands and moving averages. Free with an account.

Institutional ownership

Are big funds buying or selling CLX?

86 of the 185 tracked managers added to CLX in their latest 13F and 97 trimmed. Together they own 69.5% of the company, worth $8.1B. BlackRock and State Street alone hold 15.0%.

86adding97trimming2unchanged
Largest holders by stake, latest 13FBar = share of CLX
  1. $958.6M positionTrimmed 1.3% last quarter
  2. $804.8M positionAdded 2.2% last quarter
  3. $753.6M positionAdded 0.6% last quarter
  4. $573.6M positionAdded 23.7% last quarter
  5. $553.5M positionAdded 0.3% last quarter
  6. $310.4M positionAdded 1.1% last quarter
  7. $283.7M positionTrimmed 7.6% last quarter
  8. $214.4M positionTrimmed 17.3% last quarter
  9. $197.8M positionAdded 199.6% last quarter
  10. $189.0M positionAdded 116.6% last quarter
Full holdings history

Congressional trading

Is Congress trading CLX?

7 members of Congress disclosed 25 CLX trades between Feb 19, 2014 and May 15, 2026: 11 buys and 14 sells, about $650.0K in estimated value.

BuysSells201620182020202220242026
BuySell$1K–$15K$15K–$50K$50K–$100K$100K–$250K

What stands out

Click one to highlight its trades in the chart

Discover more

How has CLX done against its peers?

Over the six months to Nov 6, CLX returned +8.1%. Of the 7 related stocks, 6 did better, led by EL at +23.4%.

Change since May 6, through Nov 6
−20%0%+20%+40%May 6JunJulAugSepOctNov 6EL +23.4%CLX +8.1%MO +7.7%